Full name
EPPENDORF POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
33.13.Z - Repair and maintenance of electronic and optical devices
46.51.Z - Wholesale trade
46.52.Z - Wholesale trade
46.69.Z - Wholesale trade
47.7 - Retail sale of other products excluding motor vehicles, including motorcycles
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,7 | 8,1 | 4,9 | -39,8 |
EBITDA | 6 | 8,3 | 4,8 | -41,4 |
Short time liabilities | 5,1 | 14,3 | 8,6 | -40,1 |
Equity capital | 9,3 | 14,1 | 16 | 13,6 |
Operating profit (EBIT) | 5,9 | 8,1 | 4,7 | -42,5 |
Assets | 15,9 | 30 | 26,3 | -12,4 |
Net profit (loss) | 4,4 | 6,5 | 3,8 | -41,6 |
Cash | 8,8 | 19,7 | 19,7 | 0,4 |
Liabilities and provisions for liabilities | 6,6 | 16 | 10,3 | -35,3 |
Net income from sale | 39,7 | 53,6 | 47,1 | -12,1 |
Working assets | 15 | 29,3 | 25,5 | -12,8 |
Depreciation | 0,2 | 0,2 | 0,2 | 8,3 |
% | % | % | p.p. | |
Profitability of capital | 47,2 | 46,4 | 23,9 | -22,5 |
Equity capital to total assets | 58,6 | 46,8 | 60,7 | 13,9 |
Gross profit margin | 14,3 | 15 | 10,3 | -4,7 |
EBITDA Margin | 15,2 | 15,4 | 10,3 | -5,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 46 | 98 | 67 | -31 |
Current financial liquidity indicator | 2.8148605823516846 | 1.989958643913269 | 2.776369333267212 | 0,8 |
Net dept to EBITDA | -1.4594053030014038 | -2.3773040771484375 | -4.076866626739502 | -1,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane